Adult Immunization 2010 Hepatitis A Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

Slides:



Advertisements
Similar presentations
Hepatitis B Campaign 28 July.  HEPATITIS B is a liver disease caused by the hepatitis B virus (HBV). WHAT IS HEPATITIS B DISEASE?
Advertisements

Vaccine Update and Refresher for Immunizations: 2012 Krista D. Capehart, PharmD, MSPharm, AE-C David G. Bowyer, R. Ph. Assistant Professors of Pharmacy.
Administration by Emergency Medical Services Personnel
IMMUNIZATION Immunization??? Reduce mortality and morbidity of mathernal and baby.
Influenza and Influenza Vaccine
DO HEALTHY CHILDREN NEED TO GET VACCINATED?. Rationale for childhood vaccination Annual influenza vaccine is widely recommended for children at high risk.
Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Diphtheria and Diphtheria Toxoid
Tetanus and Tetanus Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
1 Blood borne occupational health risks Terhi Heinäsmäki, MD March 10, 2004 Tartu, Estonia.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Poliomyelitis First described by Michael Underwood in 1789 First outbreak described in U.S. in ,000 paralytic cases reported in the U. S. in 1952.
Adult Immunization 2010 Hepatitis B Vaccine Segment
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Vaccine Information Statement Hepatitis B (7/11/01) 42 U.S.C. § 300aa-26.
Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:
Adult Immunization 2010 MMR Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.
Varicella Zoster Virus Herpesvirus (DNA) Primary infection results in varicella (chickenpox) Recurrent infection results in herpes zoster (shingles) Short.
What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
MEASLES VACCINATION 2015 Update Susan Reeser RN, BSN (406)
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Hepatitis B Virus 28.
Hepatitis A or Hepatitis E? AM Report 5/19/09 Anne Peery MD.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis D (Delta) Virus Division of Viral Hepatitis.
Viral Hepatitis - Historical Perspective A “Infectious” “Serum” Viral hepatitis Entericallytransmitted Parenterallytransmitted F, G, ? other E NANB BD.
Updated ACIP Recommendations for Using Hepatitis A Vaccine for Postexposure and International Travel Management Miriam J. Alter, Ph.D., MPH Infectious.
1 Hepatitis A and B Vaccination and the New York State Adult Hepatitis Vaccination Program Elizabeth Rausch-Phung, MD MPH Medical Director, NYSDOH Bureau.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Polio and Polio Vaccine
Adult Immunization 2010 Pneumococcal Segment This material is in the public domain This information is valid as of May 25, 2010.
Diphtheria and Diphtheria Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Measles, Mumps and Rubella Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville
Tetanus and Tetanus Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
16/3/20091Dr. Salwa Tayel. 16/3/20092Dr. Salwa Tayel Viral Hepatitis.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Influenza Vaccine Segment Graphics subject to change. This material in the public domain.
Tetanus and Tetanus Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
HEPATITIS A EISENMAN ARIE, M.D Department of Internal Medicine B Rambam Medical Center Haifa, Israel
Influenza chemoprophylaxis Foroud Shahbazi, Pharm.D.
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
MENINGOCOCCAL POLYSACCHARIDE PNEUMOCOCCAL POLYSACCHARIDE TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Hepatitis B and Hepatitis B Vaccine
Meningococcal Disease and Meningococcal Vaccines
Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at
SAMANTHA ALLEN PHARMACY STUDENT PHARMD CANDIDATE 2012 SEPTEMBER 27, 2011 Hepatitis B Vaccination in Cirrhotic Liver Transplant Candidates.
Date of download: 5/27/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Recommended adult immunization schedules, United States, 2011.
Date of download: 5/27/2016 From: Recommended Adult Immunization Schedule: United States, 2009(1) Ann Intern Med. 2009;150(1): doi: /
Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):
Polio and Polio Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
Diphtheria and Diphtheria Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Mumps and Mumps Vaccine
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
What’s Up With All Those Other Vaccines?
Presenter ITODO EWAOCHE
Immunization Update 2007 Rotavirus Vaccine Segment
The virus that does not cause chronic liver disease
is caused by the Hepatitis A virus (HAV)
Immunization Update 2007 Tdap Vaccine Segment
JE vaccine eligibility
Immunization Update 2007 Varicella Vaccine Segment
Presentation transcript:

Adult Immunization 2010 Hepatitis A Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010

Hepatitis A Fecal-oral transmission Indistinguishable from other types of hepatitis Does not lead to chronic infection Complications related to the acute disease

Hepatitis A Vaccines Inactivated whole virus –HAVRIX –VAQTA Single dose with a booster dose 6 to 18 months after the first dose Supplied as a liquid in prefilled syringes and single dose vials

Twinrix Hepatitis B (adult dose) and hepatitis A (pediatric dose) 3-dose series at 0, 1, 6 to12 months 4-dose series at 0, 7, 21 to 30 days, booster at 12 months Approved only for adults 18 years of age and older

Schedules That Include Both Twinrix and Hepatitis A Vaccine Adult formulation single-antigen hepatitis A vaccine may be used to complete a schedule begun with Twinrix and vice versa Acceptable schedules –2 Twinrix and 1 hepatitis A –1 Twinrix and 2 hepatitis A Maintain spacing recommended for Twinrix –1 month between doses 1 and 2 –5 months between doses 2 and 3

Hepatitis A Vaccine Recommendations International travelers Men who have sex with men Injection and noninjection drug users Persons with occupational risk (limited to certain laboratory personnel and animal handlers) Persons with chronic liver disease MMWR 2006;55(RR-7)

Hepatitis A Vaccine Recommendations All previously unvaccinated persons who anticipate close personal contact with an international adoptee from a country of high or intermediate endemicity during the first 60 days following arrival of the adoptee in the United States The first dose should be administered as soon as adoption is planned MMWR 2009;58(36):1006-7

Hepatitis A Vaccine International Travel The first dose of hepatitis A vaccine should be administered as soon as travel is considered For healthy persons 40 years of age or younger: –1 dose of single-antigen vaccine administered at any time before departure Persons at risk of severe disease from hepatitis A virus planning to travel in 2 weeks or sooner should receive the first dose of vaccine and also can be administered immune globulin MMWR 2007;56(41):1080-4

Hepatitis A Postexposure Prophylaxis For healthy persons 12 months through 40 years of age: –single-antigen hepatitis A vaccine should be administered as soon as possible after exposure For persons older than 40 years: –immune globulin is preferred –vaccine can be used if IG cannot be obtained MMWR 2007;56(41):1080-4

Hepatitis A Vaccine Contraindications and Precautions Severe allergic reaction to a vaccine component or following a prior dose Moderate or severe acute illness MMWR 2006;55(RR-7)

Hepatitis A Vaccine Adverse Reactions Local reactions20%- 50% Systemic reactions (fever, malaise) <10% No serious adverse reactions reported MMWR 2006;55(RR-7)

National Center for Immunization and Respiratory Diseases Contact Information Telephone (800) CDC-INFO Website Broadcast Updates and Resources Web Page